Purpose of Review With the increasing interest in recycling water for potable reuse purposes, it is important to understand the microbial risks associated with potable reuse. This review focuses on potable reuse systems that use high-level treatment and de facto reuse scenarios that include a quantifiable wastewater effluent component. Recent Findings In this article, we summarize the published human health studies related to potable reuse, including both epidemiology studies and quantitative microbial risk assessments (QMRA). Overall, there have been relatively few healthbased studies evaluating the microbial risks associated with potable reuse. Several microbial risk assessments focused on risks associated with unplanned (or de facto) reuse, while others evaluated planned potable reuse, such as indirect potable reuse (IPR) or direct potable reuse (DPR). Summary The reported QMRA-based risks for planned potable reuse varied substantially, indicating there is a need for risk assessors to use consistent input parameters and transparent assumptions, so that risk results are easily translated across studies. However, the current results overall indicate that predicted risks associated with planned potable reuse scenarios may be lower than those for de facto reuse scenarios. Overall, there is a clear need to carefully consider water treatment train choices when wastewater is a component of the drinking water supply (whether de facto, IPR, or DPR). More data from full-scale water treatment facilities would be helpful to quantify levels of viruses in raw sewage and reductions across unit treatment processes for both culturable and molecular detection methods.
Introduction
Population growth, urbanization, and drought have stressed water supplies worldwide. To strengthen water portfolios, municipalities are increasingly considering innovative water management strategies, including water reuse. Potable reuse, where the drinking water source includes recycled wastewater, can be categorized as planned reuse and unplanned reuse [1, 2] .
Planned Potable Reuse Planned potable reuse encompasses indirect potable reuse (IPR) and direct potable reuse (DPR). Potable reuse is considered indirect when advanced treated wastewater enters an environmental buffer, such as a reservoir or groundwater basin, prior to conventional drinking water treatment [2] . In the past, IPR has most appealed to communities because passage through an environmental buffer can further improve water quality through pathogen removal/ inactivation and provide dilution of treated wastewater contaminants. Additionally, retention in the environment provides time for treatment excursions to be detected and corrected before water reaches the public [2, 3] . Several notable IPR project examples include groundwater recharge and direct injection projects in California (Orange County Sanitation District) and surface water augmentation in the Republic of Singapore (NEWater plants) [2] .
Potable reuse is considered direct when the advanced treated wastewater enters a drinking water supply, without prior
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discharge to an environmental buffer [2] . The advanced treated wastewater may be retained in an engineered storage buffer, blended with raw ambient water (e.g., from reservoir or river), blended with conventionally treated drinking water, or added directly into the drinking water distribution system. Until recently, DPR projects were extremely rare. However, DPR is gaining acceptance among water professionals, State regulators, and the public. In some cases, environmental buffers are unavailable, in other cases DPR may be more cost-efficient than IPR options or provide the ability to expand available water quantity [4] . Several existing or proposed DPR projects include those in Windhoek, Namibia; Cloudcroft, New Mexico; and El Paso, Texas [5, 6••] . Of note, Namibia has the most extensive DPR experience in the world (50 years). Additionally, the project in El Paso, Texas, includes a DPR scheme in which the DPR product water will enter the potable water distribution system directly from the advanced water treatment facility [7, 8] . Advanced water treatment facilities employ a range of unit processes, many of which are combined to increase pathogen and chemical removals. Processes may include, but are not limited to, reverse osmosis, ultraviolet radiation, and ultrafiltration.
Unplanned Potable Reuse Unplanned potable reuse, also known as "de facto" reuse, is the incidental presence of treated wastewater in a downstream water supply source [2, 9] or septage recharge of ground water supplying a public well [10] . The magnitude of de facto reuse is geographically widespread and increasing [2, 11] . Recently, Rice and Westerhoff [9] reported that upstream wastewater treatment plant (WWTP) discharges potentially contribute to source waters used at 50% of the drinking water treatment plants (DWTPs) that serve greater than 10,000 people; and that low streamflow conditions could be of concern, particularly for smaller systems and under drought conditions [12] .
Current Recommendations for Potable Reuse
No federal regulations in the USA specifically address potable reuse [6••] or the co-location of DWTPs in relation to WWTP discharge sites upstream of the same water source [9] . But, the states may choose to implement potable reuse practices using the Safe Drinking Water Act and Clean Water Act as a foundation [6••] . For example, IPR projects in California apply a "12/10/ 10 Rule," where viruses should be reduced by 12-logs, and Cryptosporidium and Giardia by 10-logs each [13, 14] . These log-reduction values are intended to achieve a benchmark level of public health protection of 1 infection in 10,000 people per year (10 −4 ), and were initially derived from reported densities of culturable enteric viruses, G. lamblia, and Cryptosporidium spp. found in raw sewage [14, 15, 16] . California is now considering the same microbial logreduction requirements for DPR projects [17•] . The World Health Organization (WHO) published pathogen reduction target recommendations for potable reuse using a health burden (disability-adjusted life year-DALY) risk-based approach, resulting in somewhat less stringent log-reduction estimates-enteric viruses should be removed by 9.5-logs, bacteria by 8.5-logs, and protozoa by 8.5-logs [18•] .
With the increasing interest in using recycled water for potable reuse, it is important to understand the microbial risks associated with potable reuse. In this review, we address this need through the following objectives: (1) discuss common microbial pathogens associated with raw sewage; (2) summarize the published health assessments related to potable reuse, including both quantitative microbial risk assessments (QMRA) and epidemiologic studies; and (3) synthesize the potable reuse risk literature in terms of overall conclusions and considerations.
Pathogens of Concern
Given the nature of the source water, risks from microbial constituents are of particular concern when potable reuse is considered [1] and it is critical pathogens are removed sufficiently to prevent acute adverse health effects [2] . In general, the classes of microbes that can cause infection in humans include pathogenic bacteria, viruses, and protozoa, most of which are transmitted via a fecal-oral route.
Bacteria Pathogenic bacteria commonly associated with raw wastewater include, but are not limited to, Salmonella spp., Campylobacter spp., and pathogenic Escherichia coli. These bacteria generally result in self-limiting, acute gastroenteritis in healthy adults. However, more severe illness outcomes, such as hemolytic uremic syndrome (HUS) caused by E. coli O157:H7, as well as long-term sequelae such as GuillainBarré syndrome associated with Campylobacter and other pathogens, can also occur.
Due to their size and cell wall composition, bacteria are generally more susceptible to treatment and disinfection than viruses and protozoa. Spore-forming bacteria are an exception that can withstand high temperatures and disinfection treatments [19] . Additionally, some bacteria, such as Legionella spp., can proliferate in drinking water distribution systems and biofilms [20] .
Viruses Human enteric viruses of concern in raw wastewater include noroviruses (NoV), enteroviruses, hepatitis A virus, rotaviruses, and adenoviruses (AdV) [21] . Viruses, particularly non-enveloped viruses, are important to potable reuse applications because of their small size (0.02-0.03 μm), resistance to disinfection, and ability to cause infection at low doses [22] . Smaller pore sizes (< 0.02 μm), such as those in reverse osmosis and nanofiltration, are needed to significantly remove viruses found in wastewater [23] . Additionally, many non-enveloped viruses are resistant to commonly used disinfectants, such as monochloramine, and AdV are particularly resistant to ultraviolet disinfection (UV) [21] .
Human enteric viruses are present in raw and chlorinated secondary effluent [24••, 25••] , to a lesser degree in tertiary effluent [26] , and can even persist in effluents after some advanced treatment [27, 28] . Most waterborne illnesses are thought to be associated with viruses [29] , with NoV causing the greatest number of gastrointestinal illnesses in the USA (> 20 million episodes, 569 deaths per year) [29] . However, NoV are difficult to culture [30] , which creates challenges in understanding their rate of inactivation through treatment and disinfection processes.
Parasitic Protozoa The pathogenic protozoa most commonly associated with raw wastewater are Cryptosporidium spp. and Giardia lamblia. Pathogenic protozoa are of concern in potable reuse applications because of their resistance to treatment and disinfection (particularly the cysts and oocysts of the protozoan life cycle), and ability to cause infection at low doses (i.e., one oocyst) typical of environmental exposures [31•] . Cryptosporidium oocysts and Giardia cysts are often detected in secondary wastewater effluent [32] and may persist in disinfected effluent after granular media or membrane filtration [33] . Some recent studies highlight the lack of published correlations between removal/inactivation of Cryptosporidium and secondary effluent water quality as evaluated via traditional fecal indicator bacteria [34] .
Potable Reuse Reference Pathogens Soller et al. [35••] summarized the reported densities of key pathogens in raw wastewater, which included NoV, AdV, Giardia spp., Cryptosporidium spp., Campylobacter spp., and Salmonella enterica. Together, these reference pathogens comprise more than 75% of illnesses from all known pathogens in the USA [29, 36] and are representative of other pathogens potentially of concern from the waterborne exposure route [37] [38] [39] . Since these pathogens cause the vast majority of known illnesses, it is assumed these same pathogens will be present in raw sewage. Soller et al. [35••] also summarizes the range of reductions of each of the key reference pathogens across individual unit treatment processes.
Review of Epidemiology and QMRA Studies for Potable Reuse
It is difficult to make inferences about public health safety via monitoring of microbial pathogens in the product water from advanced water treatment facilities because practical detection limits are much higher than the densities corresponding to benchmark levels of risk [40••] . Therefore, studies evaluating adverse human health impacts associated with exposure to pathogens from potable reuse can help fill this gap. Epidemiological studies have been a traditional approach for studying risks of waterborne pathogen exposure generally, and more recently QMRA has been used, particularly as a comparative risk tool [22, 41] . Following is a summary of epidemiology and risk assessment studies that have been completed to date evaluating the safety of potable water reuse, considering the microbial risks.
Epidemiology Studies DPR began in Windhoek, Namibia, in 1968. The DPR treatment train consisted of powdered activated carbon, pre-ozonation, enhanced coagulation and flocculation, dissolved air flotation, dual media filtration, ozonation, biological activated carbon, granular activated carbon, ultrafiltration, chlorination, and stabilization with caustic soda. Retrospective epidemiological evaluations of that population have found no relationships between the drinking water source and diarrheal disease, jaundice, or mortality [2, 42] . However, because of limitations of in theWindhoek epidemiological studies including the inadequate power, retrospective study design, unique environment, and demographics extrapolations to other populations in industrialized countries are not possible [2, 43] .
Recycled water, Colorado River water and local stormwater runoff, have been used since 1962 as sources for replenishing the Central Groundwater Basin at the Montebello Forebay in Los Angeles County [2] . Recycled water was provided by three tertiary water reclamation plants, each providing sedimentation, activated sludge secondary treatment, coagulation, flocculation, granular activated carbon, disinfection with chlorine, and dechlorination. Three ecologic epidemiology studies have been conducted to assess the health significance of the use of recycled water at this location. The studies focused on a broad spectrum of health concerns that could potentially be attributed to constituents in drinking water and compared the health outcomes for 900,000 people who received some recycled water in their household water supplies to a control area of 700,000 people with similar demographic and socioeconomic characteristics, but who did not receive recycled water. The results from the collective studies [44] [45] [46] found no association between exposure to recycled water and higher rates of cancer, mortality, infectious disease or adverse birth outcomes. A fourth health study conducted in the Montebello Forebay [47] assessed the rates that residents consulted with primary care physicians for gastroenteritis, respiratory complaints, and dermatological complaints (conditions that could be related to reclaimed water exposure). No differences in consultation rates between the residents in the recycled water area and those in the conventional water area were reported. In these studies, the actual exposure to recycled water was not known or quantified because residence location was used as a proxy for actual exposure to recycled water.
Chanute, Kansas (USA), experienced a drought in 1956 and 1957 requiring the implementation of an emergency IPR scheme involving a dam on the Neosho River. A portion of intake to the drinking water plant was municipal wastewater, and an epidemiology study was completed investigating the number of cases of stomach and intestinal illness during this period. The study concluded that a fewer number of cases of stomach and intestinal illness were reported to local physicians when recycled water was being consumed versus the number of cases reported during the following winter when the conventional water supply was being utilized [6••, 48] . Some physicians suspected that this finding might have been explained by the fact that consumer acceptance of the water was poor during the event, and many people obtained their drinking water from other sources [48] .
Microbial Risk Assessments The National Academies of Science [43] compared the risk associated with planned potable groundwater reuse projects to a de facto reuse scenario. Hypothetical scenarios evaluated the relative risk from exposure to pathogens in a (1) de facto reuse scenario (assumed 5% disinfected wastewater effluent upstream in drinking water plant intake), (2) planned reuse scenario of groundwater recharge to a potable aquifer via surface spreading basins with subsequent soil aquifer treatment, and (3) planned reuse scenario of groundwater recharge to a potable aquifer by direct injection of reclaimed water receiving subsequent advanced water treatment. The reference pathogens included AdV, NoV, Salmonella enterica, and Cryptosporidium. The results indicate that both planned groundwater recharge scenarios have lower predicted risks relative to the de facto scenario, especially from viral pathogens in water receiving soil aquifer treatment, and from all four pathogens in the water receiving advanced water treatment. The authors concluded that predicted microbial risks from the planned potable reuse scenarios are much less than those from de facto reuse.
Tanaka et al. [49] evaluated the predicted risks associated with groundwater recharge in California using secondary effluent data for culturable enteric viruses. The scenario assumed 1 L of water ingestion daily, a 6-month aquifer retention time, direct chlorination of secondary effluent, a rotavirus dose-response model, and a first order decay constant of 0.1/ day [50] . The predicted mean annual risks associated with the groundwater recharge scenario were less than 10 −10 for all four treatment facilities evaluated. These results are consistent with a prior and similar groundwater recharge scenario assessment that assumed 1 and 111 viruses/100 L in chlorinated tertiary effluent, which estimated annual median and maximum risks at 10 −9 and 10 −7
, respectively [50] . Ander and Forss [51] evaluated the predicted annual risk of infection from NoV, Giardia, and Cryptosporidium for drinking water consumers under nine different scenarios that represent nominal, outbreak, and failure scenarios in Windhoek, Namibia. The median raw water densities used in the risk assessment were 0.002 NoV gene copies/L, 0.250 Giardia cysts/L, and 0. cysts/L of Giardia; and 10 3 cfu/L of Campylobacter. However, the densities increased by orders of magnitude under the assumed outbreak conditions. For example, the NoV outbreak sewage density was five orders magnitude higher than the municipal sewage density. Using the WHO-based 10 −6 DALY health target, the required LRVs were calculated to be 6.9, 8.0, and 7.4 for NoV, Giardia, and Campylobacter using municipal sewage density estimates, and 12. [34] . In three of the TTs, the DPR product water was assumed to directly enter the drinking water distribution system after advanced water treatment. In the fourth TT, DPR product water was assumed to receive further treatment via a DWTP, prior to entering the drinking water distribution system. Peer-reviewed data were summarized to characterize densities of six reference pathogens (NoV, AdV, Cryptosporidium spp., G. lamblia, C. jejuni, and S. enterica) in raw wastewater and the reduction of each across the individual unit treatment processes under consideration. Key findings were the following: (1) TTs can be configured to be effective in removing reference pathogens to levels that present low public health risk; (2) health-based advantages exist for DPR projects in which product water from an advanced water treatment facility is introduced into the raw water supply immediately upstream of a conventional DWTP compared to those in which advanced treatment product water is introduced directly into a potable distribution system; (3) predicted annual risk estimates for any particular TT are driven by the highest daily risks for any of the individual reference pathogens; (4) proposed DPR project designs need to carefully consider reduction of both Cryptosporidium spp. and NoV; and (5) expected performance of individual unit treatment processes within an integrated TT can be critical for consistently achieving the benchmark level of public health protection. Of particular note, when UV unit treatment processes are operated at the higher UV dose (800 mJ/cm 2 compared to 12 mJ/cm 2 ), the associated relative pathogen risk is significantly less than the risk associated with the lower UV dose.
In a follow-up analysis, Soller et al. [35• •] conducted a series of sensitivity analyses, evaluated the predicted risks associated with log credit allocations in the USA, and identified reference pathogen reductions needed to consistently meet currently applied benchmark risk levels. The simulation results illustrated changes in cumulative annual risk estimates, the significance of which depended on the pathogen group driving the risk for a given TT. For example, updates to NoV raw wastewater values [24••] and use of a NoV doseresponse approach capturing the full range of uncertainty [54•] increased risks associated with one of the TTs evaluated, but not the other. The most striking results from this study were that viruses need to be reduced by 14-logs or more to consistently achieve currently applied benchmark levels of protection associated with DPR, which is 2-logs greater than California requires for IPR projects (the "12/10/10 Rule").
Pecson et al. [3] collected treatment performance data (i.e., total organic carbon, UV intensity) over a 1-year period from a DPR demonstration facility in California to characterize the predicted risk associated with consumption of the product water. The advanced treatment portion of the TT consisted of ozone, BAC, MF, RO, high-dose UV with an advanced oxidation process, and chlorination with free chlorine. Modeled raw water reference pathogens evaluated included culturable enterovirus (lognormal mean = 3.19 MPN/L) and Cryptosporidium (lognormal mean = 2.72 oocysts/L) [26] . Based on the modeled log reduction for each of the unit processes in the TT, they estimated that the median log reduction the plant achieves is 14-logs for enteric viruses, 16-logs for Cryptosporidium, and~19-logs for Giardia. Using previously published risk assessment methods [55] , the predicted median annual risks for Cryptosporidium were 10 −11 and median culturable enteric virus risks were 10 −14 . Chaudhry et al. [40• •] compared a de facto water reuse scenario with four hypothetical DPR scenarios for NoV, Cryptosporidium, and S. enterica. They assessed the predicted microbial risks of using (1) source water impacted by 0-100% treated wastewater effluent and (2) different blending ratios (0-100%) of surface water with advanced treated water, assuming that the surface water consisted of 50% wastewater effluent. Median raw wastewater densities used in the analysis were approximately 9000 NoV gene copies/L (based on results from North America only reported by Eftim et al. [ 2 4 • • ] ) , 1 3 0 0 S a l m o n e l l a s p p . M P N / L , a n d 1 0 Cryptosporidium oocysts/L. Predicted de facto reuse risks exceeded the annual 10 −4 infection benchmark risks, while all modeled DPR risks were significantly lower. The risks were dominated by Cryptosporidium and NoV; however, the rank order varied depending upon the TT and doseresponse model used for NoV. The authors concluded that contributions of 1% or more of wastewater effluent in the source water, or blending 1% or more of wastewaterimpacted surface water into the advanced treated DPR water, had substantial impacts on the modeled risks. Lim et al. [56••] evaluated the predicted risk associated with de facto wastewater reuse in the Trinity River, Texas, for exposure to Cryptosporidium and NoV. The Trinity River supplies over 50% of the water to Lake Livingston, a Houston drinking water reservoir. Under base flow conditions, the Trinity River is dominated by wastewater effluent, but occasionally effluent constitutes 100% of the river flow [2] . Both the fraction of wastewater effluent in the lake and the water residence time vary significantly with season. Empirical cumulative probability distributions from literature-based pathogen density data for Cryptosporidium and NoV in conventional activated sludge WWTP effluent were used in the QMRA model. Environmental pathogen decay rates of 0.0155 log 10 /day for Cryptosporidium [57] and 0.01 log 10 /day (based on murine norovirus) for human NoV were used [58] . The annual infection risks due to Cryptosporidium and NoV as a function of different wastewater effluent proportions (15, 30 , and 45%) and residence times (270, 315, and 360 days) were computed. All scenarios resulted in risks exceeding the benchmark risk of 10 −4 infections per year, and the predicted median annual risks for both Cryptosporidium and NoV were 10 −2 . Additionally, WHO DALY guideline values were met only when storage residence times reached 360 days. Based on these results, they inferred that human exposure to drinking water produced from de facto reuse presents considerably higher infection risks than the benchmark level of often used for safe drinking water, and suggested that the community gastrointestinal illness levels are possibly a reflection of the disease burden from de facto reuse. Additionally, the authors concluded that prolonging source water storage may be more important than controlling the percent of effluent entering the drinking water source, assuming a constant temperature and pathogen decay rate.
Amoueyan et al. [59•] evaluated the reliability and equivalency of three different potable reuse scenarios for the predicted risk of infection from Cryptosporidium: (1) surface water augmentation via de facto reuse with conventional wastewater treatment; (2) surface water augmentation via planned IPR with ultrafiltration, pre-ozone, biologically activated carbon, and post-ozone; and (3) DPR with ultrafiltration, ozone, biologically activated carbon, and UV disinfection. The Cryptosporidium LRVs assumed for the scenarios were 4.0-6.5 for de facto reuse, 14.1-16.6 for IPR, and 13 for DPR. Predicted mean annual risks of infection were~10 −4 for the de facto scenario and the planned IPR system, and 10 −11 for the DPR scenario. Because the IPR system was highly effective in reducing Cryptosporidium, the associated risks were generally dominated by the pathogen loading in the surface water. As a result, predicted IPR risks generally decreased with higher recycled water contributions. Similar to Chaudhry et al. [40••] , storage time in the environment was important for the de facto reuse system with a critical storage time of approximately 105 days, although the results were temperature dependent and also increased with higher raw wastewater Cryptosporidium densities (e.g., when outbreak conditions were assumed). Storage times shorter than the critical value resulted in significant increases in predicted risk and potential impacts of unit process treatment failures were noted for the IPR system [59•].
Synthesis, Considerations, and Future Needs Synthesis
Overall, there have been relatively few health-based studies evaluating the microbial risks associated with potable reuse. The few published epidemiology studies to date have not identified any patterns of illness related to ongoing water reuse projects [2, [43] [44] [45] [46] ; however, many suffered from study design deficiencies and lacked sufficient power to detect such low-level adverse health effects. Future epidemiology studies could be designed to evaluate the human health risks associated with potable reuse, particularly to understand the risks associated with de facto reuse scenarios. Studies should consider sample size, locations with known upstream wastewater effluent impacts into drinking source waters (i.e., Trinity River) [56••] , and widespread population-based surveillance using newer infectivity detection methods, such as salivary or serological antibody multiplex immunoassays [60] . Regarding published microbial risk assessments, several studies focused on risks associated with de facto reuse, while others evaluated planned potable reuse. Results from the collective QMRA studies are compiled and summarized in Fig. 1 (refer to Supplemental Materials for more details).
In the QMRA studies evaluating de facto reuse (green symbols, Fig. 1 were met only when storage residence times reached 365 days. Amoueyan et al. [59•] reported a critical storage time of approximately 105 days for Cryptosporidium risks, although the results were temperature dependent and a function of the raw wastewater pathogen densities. Unfortunately, in many situations, residence times in an environmental buffer are difficult to control. These findings suggest that engineered storage buffers are also likely to be an important component of any DPR scheme. Additionally, Chaudhry et al. [40••] reported that as little as 1% (or more) wastewater effluent in the source water can substantially elevate drinking water risks. The above findings from de facto reuse QMRA studies are consistent with the epidemiological results reported by Colford et al. [61] , who measured a high illness rate attributable to drinking water at a site which may have included a de facto reuse drinking water component in a suitably powered randomized control trial epidemiological study [62] . With respect to planned potable reuse (IPR (red) and DPR (blue) symbols, Fig. 1 ), the reported predicted risks vary substantially, but overall the results indicate that the predicted risks associated with the planned potable reuse scenarios may be lower than those for the de facto reuse scenarios [2, 40••, 56••] . Figure 1 also illustrates the importance of the raw sewage pathogen density estimates applied in various risk models and their impact on overall risk estimates. For example, Ander and Forss [51] reported extremely low risks in almost all DPR scenarios, but they also assumed very low viral pathogen densities. Similarly, using relatively low pathogen densities in their risk model coupled with high UV doses, Pecson et al. [3] reported annual median culturable virus risks of~10 −14 and annual median risks from Because of the rapidly growing fields of QMRA and water reuse, it would be prudent for risk scientists to identify consistent input parameters for the above metrics, so that results are easily translated across studies.
Considerations
Achieving the Target Risk Level Potable reuse TTs employ multiple barriers to remove the diverse pathogens found in wastewater. Currently, the WHO suggests a 10 −6 DALY per year health endpoint [18•] , and an endpoint of 10 −4 infections per year is currently used in the USA to ensure sufficient pathogen reduction occurs across potable reuse water treatment [1, 14, 63] . Severe drought and emergency conditions aside, these benchmarks appear to be generally accepted but could be challenged in the future. Early risk-based calculations for potable reuse in the USA were derived from total culturable virus densities in raw sewage [14, 49, 50] . [69] . Since de facto reuse is such a common occurrence in the USA [9, 11] , conventional DWTPs may need to consider treatment schemes more like planned IPR, if the source water includes a de facto component and risk-based health benchmarks are to be consistently achieved.
Use of Surrogates It is important to differentiate between the actual level of pathogen removal and that which can be rapidly and continuously demonstrated [3] . In lieu of direct pathogen measurements (i.e., enumeration of pathogenic viruses after advanced water treatment), surrogates are frequently used to provide continuous evaluation of system performance. Typically, treatment facilities receive less reduction credit than what actually occurs through the unit treatment processes [35••] . These circumstances create opportunities, such as the use of non-pathogenic microbial surrogates in lieu of pathogens or fine-tuning log-credits for an individual unit process based on microbial or non-microbial surrogate measurements [70, 71] . However, before log credit allocations for individual unit processes are adjusted or alternative unit treatment processes are substituted, it will be important to ensure confidence and accuracy in the actual reductions consistently provided by a treatment process.
Antimicrobial Resistance
The presence of antimicrobialresistant bacteria and genes in treated wastewater is an issue which is currently emerging as an important consideration for potable reuse [18•] . Resistance to key clinical antibiotics is a substantial worldwide public health problem, and concerns have been raised about the exposure to antimicrobial resistant bacteria and genes in water [17•, 18•] . While bacteria are largely removed or inactivated during drinking water treatment, the extent to which resistant genes are present during the various stages of treatment and removed by individual unit processes has largely not been determined, and thus is considered a future research need.
Conclusions and Future Needs
The compilation of information presented here highlights the need to carefully consider water treatment choices when wastewater is a component of the drinking water supply (whether de facto, IPR, or DPR). Overall, we found that QMRA is a useful tool for predicting risks in the various potable water reuse scenarios, but there is a need for consistent input assumptions, particularly for pathogen densities and dose-response models. For example, risk assessments that used lower pathogen density values typically reported lower predicted risks, as compared to studies that used more recent and/or higher pathogen densities (Fig. 1) . More full-scale data from water treatment facilities using both culturable and molecular detection methods to compare levels of viruses in raw sewage and reductions across unit treatment processes would provide more confidence in microbial risk estimates. Despite differences in QMRA assumptions across studies, the reported predicted risks from planned potable reuse scenarios were consistently lower than those for the de facto reuse scenarios [2, 40••, 56••] (Fig. 1) . Since wastewater effluents discharged into environmental waters are not always required to be treated by advanced water treatment, surface waters containing conventionally treated effluent can potentially contain higher densities of pathogens than advanced treated waters [40••] .
Finally, given the limited amount of epidemiological data, epidemiology studies specifically evaluating the risks related to de facto reuse are warranted. Studies should consider sample size, locations with known upstream wastewater effluent impacts into drinking source waters (i.e., Trinity River) [56••] , and newer infectivity detection methods [60] .
